Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies
Author:
- 24 December 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology
- Vol. 59 (12_suppl_6) , S13-S21
Abstract
Intravenous immunoglobulin (IVIg) is an immunomodulating agent that has multiple activities, including modulation of complement activation products, suppressing idiotypic antibody, saturating Fc receptors on macrophages, and suppressing various inflammatory mediators including cytokines, chemokines, and metalloproteinases. Because all these factors are implicated to various degrees in the pathogenesis of immune-mediated demyelination of the PNS, administration of IVIg could be beneficial in treating neuropathies by suppressing the immune-mediated processes that are directed against myelin or axonal antigenic targets. This article outlines the actions of IVIg in CIDP and other autoimmune neuropathies based on data derived from in vivo and in vitro studies. The predominant mechanisms by which IVIg exerts its action on these neuropathies appear to be a combined effect on complement inactivation, neutralization of idiotypic antibodies, cytokine inhibition, and saturation of Fc receptors on endoneurial macrophages.Keywords
This publication has 73 references indexed in Scilit:
- Blockade of blocking antibodies in Guillain‐Barré syndromes: “Unblocking” the mystery of action of intravenous immunoglobulinAnnals of Neurology, 2002
- Acute motor axonal neuropathy: An antibody‐mediated attack on axolemmaAnnals of Neurology, 1996
- Possible mechanism of intravenous immunoglobulin treatment on anti-GM1 antibody-mediated neuropathiesJournal of the Neurological Sciences, 1996
- Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: Present and future prospectsAnnals of Neurology, 1995
- Intravenous immunoglobulin-induced osmotic nephrosisArchives of internal medicine (1960), 1994
- Effects of Intravenous Immunoglobulins (IVIG) on Peripheral Blood B, NK, and T Cell Subpopulations in Women with Recurrent Spontaneous Abortions: Specific Effects on LFA-1 and CD56 MoleculesClinical Immunology and Immunopathology, 1994
- Hyperviscosity in HIV infected children — a potential hazard during intravenous immunoglobulin therapyAnnals of Hematology, 1990
- Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.Journal of Clinical Investigation, 1990
- Anaphylactic Reactions after Gamma Globulin Administration in Patients with HypogammaglobulinemiaNew England Journal of Medicine, 1986
- Reversible and irreversible loss of Fc receptor function of human monocytes as a consequence of interaction with immunoglobulin G.Journal of Clinical Investigation, 1980